Hayek Kallen Investment Management trimmed its position in Novartis AG (NYSE:NVS – Get Rating) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 40,345 shares of the company’s stock after selling 600 shares during the period. Novartis makes […]
Abbot Financial Management Inc. trimmed its holdings in Novartis AG (NYSE:NVS – Get Rating) by 1.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 20,869 shares of the company’s stock after selling 350 shares during the period. Novartis makes up approximately 1.3% of Abbot Financial Management Inc.’s holdings, making the stock its 27th largest […]
Oarsman Capital Inc. trimmed its position in Novartis AG (NYSE:NVS – Get Rating) by 5.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,792 shares of the company’s stock after selling 365 shares during the quarter. Oarsman Capital Inc.’s holdings in […]
Oarsman Capital Inc. lowered its position in shares of Novartis AG (NYSE:NVS – Get Rating) by 5.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,792 shares of the company’s stock after selling 365 shares during the period. Oarsman […]
Horizon Kinetics Asset Management LLC decreased its position in Novartis AG (NYSE:NVS – Get Rating) by 10.9% during the fourth quarter, Holdings Channel reports. The firm owned 18,850 shares of the company’s stock after selling 2,300 shares during the quarter. Horizon Kinetics Asset Management LLC’s holdings in Novartis were worth $1,710,000 at the end of […]